Your browser doesn't support javascript.
loading
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.
Hutzler, Stefan; Erbar, Stephanie; Jabulowsky, Robert A; Hanauer, Jan R H; Schnotz, Jürgen H; Beissert, Tim; Bodmer, Bianca S; Eberle, Regina; Boller, Klaus; Klamp, Thorsten; Sahin, Ugur; Mühlebach, Michael D.
Afiliación
  • Hutzler S; Section Product Testing of IVMPs, Division of Veterinary Medicine, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, D-63225, Langen, Germany.
  • Erbar S; Biopharmaceutical New Technologies (BioNTech) Corporation, An der Goldgrube 12, D-55131, Mainz, Germany.
  • Jabulowsky RA; Biopharmaceutical New Technologies (BioNTech) Corporation, An der Goldgrube 12, D-55131, Mainz, Germany.
  • Hanauer JRH; Section Product Testing of IVMPs, Division of Veterinary Medicine, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, D-63225, Langen, Germany.
  • Schnotz JH; Section Product Testing of IVMPs, Division of Veterinary Medicine, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, D-63225, Langen, Germany.
  • Beissert T; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Freiligrathstr. 12, D-55131, Mainz, Germany.
  • Bodmer BS; Section Product Testing of IVMPs, Division of Veterinary Medicine, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, D-63225, Langen, Germany.
  • Eberle R; Section Morphology, Division of Immunology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, D-63225, Langen, Germany.
  • Boller K; Section Morphology, Division of Immunology, Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, D-63225, Langen, Germany.
  • Klamp T; Biopharmaceutical New Technologies (BioNTech) Corporation, An der Goldgrube 12, D-55131, Mainz, Germany.
  • Sahin U; Biopharmaceutical New Technologies (BioNTech) Corporation, An der Goldgrube 12, D-55131, Mainz, Germany.
  • Mühlebach MD; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Freiligrathstr. 12, D-55131, Mainz, Germany.
Sci Rep ; 7(1): 16892, 2017 12 04.
Article en En | MEDLINE | ID: mdl-29203786
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melanoma Experimental / Vacunas contra el Cáncer / Vacunas de Partículas Similares a Virus / Virus del Sarampión / Antígenos de Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melanoma Experimental / Vacunas contra el Cáncer / Vacunas de Partículas Similares a Virus / Virus del Sarampión / Antígenos de Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article País de afiliación: Alemania